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Innate  host  responses  to  microbes  rely  on 
germline-encoded pattern recognition recep-
tors (PRRs) that recognize conserved groups 
of  molecules,  PAMPs  (pathogen-associated 
molecular  patterns),  that  are  found  in  mi-
crobes. PRR signaling during antigen presen-
tation plays a critical role in influencing DC 
activation and cytokine production for tailor-
ing the subsequent adaptive immune response 
(Iwasaki and Medzhitov, 2004). DCs express 
four families of PRRs: the toll-like receptors 
(TLRs), the Nod-like receptors (NLRs), the 
RIG-I  and  Mda5  helicases,  and  the  mem-
brane-associated C-type lectin receptors (CLRs). 
Whereas DC signaling through TLRs in re-
sponse to some bacterial species is linked to 
the  induction  of  IL-12  and Th1  immunity 
(Iwasaki and Medzhitov, 2004), and signaling 
through CLRs in response to fungi is linked 
to the generation of IL-6, IL-23, and Th17 
immunity (LeibundGut-Landmann et al., 2007; 
Robinson et al., 2009), only TLR4 on lung 
stromal cells is clearly linked to the preferen-
tial  generation  of  Th2  immunity  (Hammad   
et al., 2009).
Nonmammalian glycans in helminths, fungi, 
and  plants  can  act  as  potent Th2  adjuvants. 
Schistosoma  mansoni  egg  antigen  (SEA)  elic-
its Th2 cytokines and antigen-specific IgE in 
BALB/c mice. This activity is lost with SEA 
deglycosylation,  whereas  conjugation  of  the 
germane -fucosylated oligosaccharide, lacto- 
N-fucopentaose III, to human albumin promotes 
albumin-specific Th2  cytokine  production 
and albumin-specific IgE (Okano et al., 1999, 
2001). Ara h 1, the immunodominant peanut 
allergen containing xylosylated complex man-
nose  glycans,  such  as  Man3(4)XylGlcNAc2, 
confers human monocyte-derived DCs with 
the capacity to generate IL-4– and IL-13–
producing CD4+ T cells from naive CD45RA+  
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The innate signaling pathways for Th2 immunity activated by inhaled antigens are not well 
defined. We previously identified Dectin-2 as a receptor for glycans in allergen extracts 
from the house dust mite Dermatophagoides farinae (Df) that mediates cysteinyl leukotri-
ene (cys-LT) generation from pulmonary CD11c+ cells and from GM-CSF–cultured bone 
marrow cells (BMCsGM-CSF). Using lentiviral knockdown of Dectin-2 in BMCsGM-CSF and 
adoptive transfer of Df-pulsed BMCsGM-CSF to sensitize naive mice, we now report that 
Dectin-2 is critical for the development of Df-elicited eosinophilic and neutrophilic pulmo-
nary inflammation and Th2 cytokine generation in the lungs and restimulated lymph nodes. 
Sensitization with Df-pulsed BMCsGM-CSF from LTC4 synthase (LTC4S)–deficient mice or type 
1 cys-LT receptor (CysLT1R)–deficient mice demonstrated that both proteins were required 
for Df-elicited eosinophilic pulmonary inflammation and Th2 cytokine generation in the 
lungs and restimulated lymph nodes. Direct sensitization and challenge of Ltc4s/ and 
Cysltr1/ mice confirmed that cys-LTs mediate these parameters of Df-elicited Th2 pul-
monary inflammation. Thus, the Dectin-2–cys-LT pathway is critical for the induction of 
Th2 immunity to a major allergen, in part through CysLT1R. These findings identify a previ-
ously unrecognized link between a myeloid C-type lectin receptor and Th2 immunity.
© 2011 Barrett et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Dectin-2 is a member of the myeloid CLR family that 
couples to the FcR chain to initiate ITAM (immunorecep-
tor tyrosine-based activation motif)-dependent signaling and 
the recruitment and activation of spleen tyrosine kinase (Syk; 
Ariizumi et al., 2000; Sato et al., 2006). The Dectin-2–Syk 
pathway activates the CARD9 adaptor protein in DCs to 
generate NF-B–dependent IL-2, IL-10, TNF, and IL-23p19 
and  to  promote Th17  immune  responses  to  C.  albicans 
(Robinson et al., 2009). We have previously demonstrated 
that the Dectin-2–Syk pathway also triggers the genera-
tion  of  cysteinyl  leukotrienes  (cys-LTs)  from  pulmonary 
CD11c+  cells  and  from  GM-CSF–cultured  BM  cells 
(BMCsGM-CSF) in response to glycans in allergen extracts 
from the house dust mite (HDM) species Dermatophagoides 
farinae  (Df)  and  Dermatophagoides  pteronyssinus  (Dp;  Barrett   
et al., 2009), the most common aeroallergens to elicit sensiti-
zation in humans and potent triggers of Th2- and Th17-
dependent bronchial inflammation in mice (Cates et al., 2004; 
Krishnamoorthy et al., 2008; Hammad et al., 2009; Phipps   
et al., 2009). Thus, we hypothesized that Dectin-2 is a PRR 
coupled to the generation of Th2 immune responses via 
cys-LT signaling.
T cells (Shreffler et al., 2006). In mice, the intratracheal admin-
istration of soluble -glucan (-1,3/1,6-linked) from Candida 
albicans with OVA augments the levels of elicited pulmonary 
eosinophilia, pulmonary Th2 cytokine induction, and total 
and OVA-specific serum IgE produced by the administra-
tion of OVA alone (Inoue et al., 2009), and -1,3/1,6-glucan 
from baker’s yeast can boost serum levels of OVA-specific IgE 
and IgG1, but not OVA-specific IgG2a, when added to an 
OVA footpad injection (Instanes et al., 2004). Thus, N-linked 
core -fucosylated and/or -xylosylated complex mannose 
glycans found widely in plants, insects, and helminths and   
-1,3/1,6-glucans found in fungi appear to be nonmammalian 
molecular patterns important in triggering Th2 immunity 
(Altmann, 2007; Wills-Karp et al., 2010). However, although 
members of the CLR family recognize these motifs—e.g., 
L-SIGN  (liver/lymph  node–specific  intercellular  adhesion 
molecule 3–grabbing nonintegrin) recognizes -fucosylated 
oligosaccharides in SEA (Meyer et al., 2007), DC-SIGN 
(DC-specific intercellular adhesion molecule 3–grabbing non-
integrin) recognizes xylosylated complex mannose in Ara h 1   
(Shreffler  et  al.,  2006),  and  Dectin-1  recognizes  fungal 
-glucans (Brown and Gordon, 2001)—a direct role for a   
myeloid CLR in the generation of Th2 immunity has not 
been demonstrated.
Figure 1.  Dectin-2 mediates Df-elicited cytokine pro-
duction by BMCsGM-CSF. BMCsGM-CSF were infected with viral 
particles containing Dectin-2 shRNA (kdBMCsGM-CSF), a vector 
control (cBMCsGM-CSF), or a nontargeting vector control 
(ntcBMCGM-CSF), selected with puromycin, and harvested at 
day 7. (A) Dectin-2 expression on all BMCsGM-CSF and on  
CD11chi MHCIIlow cells was assessed by flow cytometry. Left, 
results are means ± SEM (n = 4–6 mice per group) from three 
independent experiments. ***, P = 0.0001. Significance was 
determined with an unpaired Student’s t test. Right, a repre-
sentative histogram of Dectin-2 expression on all BMCsGM-CSF 
and on CD11chiMHCIIlow cells from cBMCsGM-CSF (gray), 
ntcBMCGM-CSF (light gray), and kdBMCsGM-CSF (heavy black line) 
cultures is compared. Isotype control staining on all BMCsGM-CSF 
is also shown for cBMCsGM-CSF (gray dotted), ntcBMCsGM-CSF 
(light gray dotted), and kdBMCsGM-CSF (heavy black line  
dotted). (B) Representative histograms are shown of  
CD11c expression and MHCII expression on cBMCsGM-CSF, 
ntcBMCsGM-CSF, and kdBMCsGM-CSF, with the percentage of 
CD11c positive cells noted, as gated by the isotype control 
staining on a mixture of cBMCsGM-CSF, ntcBMCsGM-CSF, and 
kdBMCsGM-CSF, designated BMCsGM-CSF. MHCII staining was 
performed with nonsaturating antibody concentrations. Gat-
ing on a CD11chiMHCIIlow Dectin-2hi subset is also indicated 
(small boxes). (C) BMCsGM-CSF were stimulated with Df at the 
indicated concentrations and the supernatant contents were 
assessed by ELISA for cys-LTs at 60 min and for cytokines at  
4 h. Results for cys-LT generation are means ± SEM (n = 6–8 
mice per group) from four independent experiments. **, P = 
0.02. Significance was determined with an unpaired Student’s 
t test. Results for cytokines are means ± SEM (n = 5–6 mice 
per group) from three independent experiments. P = 0.01 for 
IL-6, P = 0.04 for IL-10, P = 0.03 for IL-23, and P = 0.0001 for 
TNF. Significance was determined with two-way ANOVA  
(p-values refer to the integrated differences in cBMCsGM-CSF 
and kdBMCsGM-CSF over the varied doses).JEM VOL. 208, March 14, 2011 
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which was 5 ± 0.8% of total cells, expressed high levels of 
Dectin-2 in control vector BMCGM-CSF cultures and demon-
strated a significant 73.6% reduction in Dectin-2 expression 
in knockdown BMCGM-CSF cultures (Fig. 1 A, left). Dectin-2 
expression on all BMCsGM-CSF and on CD11chi MHCIIlow 
cells from ntcBMCGM-CSF was comparable to cBMCsGM-CSF 
and distinct from the reduction observed in kdBMCsGM-CSF 
(Fig. 1 A, right). Day-7 cBMCsGM-CSF, ntcBMCsGM-CSF, and 
kdBMCsGM-CSF  showed  similar  expression  of  CD11c  and 
MHCII (Fig. 1 B). The knockdown was confirmed by bioassay, 
in which kdBMCsGM-CSF demonstrated a 79.6% reduction in 
cys-LT generation after stimulation for 1 h with 100 µg/ml Df 
(Fig. 1 C). In parallel, we stimulated cells at 0, 10, or 50 µg/ml 
Df for 4 or 30 h. At 4 h, kdBMCsGM-CSF stimulated with Df 
had significant reductions in the generation of IL-6, IL-10, 
IL-23, and TNF, as compared with cBMCsGM-CSF (Fig. 1 C). 
There was no reduction in IL-2. At 30 h, kd-BMCsGM-CSF had   
significant reductions in IL-6, IL-10, and TNF, as compared 
with cBMCsGM-CSF, and a lower level of IL-23 that did not 
reach statistical significance (Fig. S2 A). kdBMCsGM-CSF had 
no reduction in TNF generation in response to LPS or to 
curdlan (Fig. S2 B) and no reduction in cys-LT generation in 
response to curdlan (Fig. S2 B), indicating the functional in-
tegrity of TLR4 and Dectin-1.
CD11c+ DCs in the bronchial mucosa sample inhaled anti-
gens and then migrate to the lung-draining lymph nodes 
while simultaneously activating a maturation program that 
results in antigen-driven T cell division. This sensitization can 
be mimicked by the intratracheal or intranasal adoptive trans-
fer of antigen-pulsed myeloid DCs to naive recipient mice 
and subsequent antigen challenge (Lambrecht et al., 2000a,b,c). 
We took advantage of this adoptive transfer system and the 
ability to knock down Dectin-2 in BMCsGM-CSF to examine 
the role of the Dectin-2–cys-LT pathway in Df-induced Th2 
and Th17 pulmonary inflammation. In this paper, we demon-
strate that Dectin-2 mediates Df-elicited generation of cys-
LTs and cytokines, including TNF, IL-6, IL-10, and IL-23, 
using lentiviral knockdown of Dectin-2 in BMCsGM-CSF 
(kdBMCsGM-CSF).  Moreover,  WT  mice  sensitized  with   
Df-pulsed kdBMCsGM-CSF and challenged intranasally with 
Df had significantly reduced pulmonary inflammation and Th2 
cytokine generation from lung and restimulated parabronchial 
lymph nodes as compared with mice sensitized with Df-pulsed 
BMCsGM-CSF infected with a vector control (cBMCsGM-CSF), 
thereby identifying Dectin-2 as a critical PRR for Th2   
immunity elicited by HDM. Furthermore, we show that the   
genetic absence of either LTC4 synthase (LTC4S), the critical 
enzyme in cys-LT generation, or the type 1 cys-LT recep-
tor (CysLT1R) on Df-pulsed BMCsGM-CSF similarly impairs 
Df-induced Th2 pulmonary inflammation in lung and lymph 
nodes, thereby demonstrating that cys-LT production and 
CysLT1R-mediated function promote Th2 sensitization.
RESULTS
Dectin-2 mediates Df-elicited production of IL-6, IL-10,  
IL-23, and TNF by BMCsGM-CSF
Before assessing the role of Dectin-2 in Df-initiated cytokine 
responses in vitro and in vivo using GM-CSF–expanded BM 
cultures, we further characterized the BMCsGM-CSF from WT 
BALB/c  mice. At  day  7,  BMCsGM-CSF  were  74.9  ±  0.7% 
CD11c+ by flow cytometry. The CD11c+ cell population 
expressed CD11b (97.7 ± 0.4%) and MHCII (88.5 ± 0.2%; 
Fig. S1 A and not depicted). Although 89 ± 3.6% of CD11c+ 
cells expressed Dectin-2, the range of expression was broad 
with  CD11chiMHCIIlow  cells  expressing  the  highest  levels 
(Fig. S1 A). 92.4 ± 0.2% of Dectin-2+ cells were CD11c+ 
(Fig. S1 B). 7.6 ± 0.2% of Dectin-2+ cells were CD11c and 
expressed CD11b and the monocyte marker Ly6C (Fig. S1 B). 
Analysis of stained cytospins revealed that 12.4 ± 0.5% of 
BMCsGM-CSF were granulocytes (not depicted), all of which 
were Dectin-2 by immunocytochemistry (Fig. S1 C).
To assess the role of Dectin-2 in Df-induced cytokine 
production, we infected day-1 BMCsGM-CSF with lentivirus 
expressing a short hairpin (sh) RNA for Dectin-2 (kd-
BMCsGM-CSF), a nontargeting sequence (nontargeting control 
BMCGM-CSF  [ntcBMCGM-CSF]),  or  an  empty  vector  alone 
(cBMCsGM-CSF). After puromycin selection of infected cells, 
kdBMCsGM-CSF demonstrated a significant 43.9% reduction 
in Dectin-2 expression by flow cytometry, as compared with 
cBMCsGM-CSF (Fig. 1 A, left). A CD11chi MHCIIlow subgroup, 
Figure 2.  BMCGM-CSF Dectin-2 is required for Df-elicited Th2 pul-
monary inflammation. WT mice were sensitized by intranasal adminis-
tration of 104 saline-pulsed or Df-pulsed kdBMCsGM-CSF or cBMCsGM-CSF at 
day 8 of culture, challenged with 2 µg Df on day 22 and day 23, and ana-
lyzed on day 25. (A) Cells from the BAL fluid were counted, cytospin prep-
arations were stained, and 400 cells/slide were counted for specific cell 
types. Results are means ± SEM (n = 13–14 mice per group) from three 
independent experiments. **, P = 0.0001; *, P = 0.001. Significance was 
determined with an unpaired Student’s t test. (B) ELISA was performed on 
BAL fluid supernatants. Results are means ± SEM (n = 14 mice per group) 
from three independent experiments. ‡, P = 0.05.596 Dectin-2 drives Th2 responses in vivo | Barrett et al.
To determine whether the reduction in BAL fluid inflam-
matory cells and cytokines reflected an impairment in the 
generation of Th2 and/or Th17 immune responses in the 
lymph nodes, we assessed cytokine generation from the lung-
draining lymph nodes of the three groups of mice. Upon   
ex vivo restimulation with 0, 1, or 5 µg/ml Df for 72 h, recipi-
ents sensitized with Df-pulsed cBMCsGM-CSF generated robust 
production of T cell cytokines, as compared with recipients of 
saline-pulsed cBMCsGM-CSF. Lymph node cells from recipients 
sensitized with Df-pulsed kdBMCsGM-CSF had significant re-
ductions at the 5-µg/ml dose in the total generation of IL-4, 
IL-5, and IL-13 per mouse of 51.7, 59.6, and 42.2%, respec-
tively, compared with recipients of Df-pulsed cBMCsGM-CSF 
(Fig. 3). IL-17A and IFN- were not different between the 
Df-pulsed groups. The reduction in IL-4, IL-5, and IL-13 
generated by recipients of Df-pulsed kdBMCsGM-CSF was the 
result of both a reduction in concentration of each cytokine 
per million cells plated and an 18.9% reduction in the total 
lymph node cell count (Fig. 3). The reductions in concentra-
tion were significant for IL-5 and IL-13, whereas the trend 
for IL-4 did not reach significance. Thus, the cytokine find-
ings of a reduced Th2 response in the restimulated nodal cells 
reflected the reduced eosinophil count and the reduced IL-13 
level in the BAL fluid. There was no reduction in IL-17A 
generation to account for the notable neutrophil reduction in 
the BAL fluid of mice sensitized with kdBMCsGM-CSF.
BMCGM-CSF cys-LT generation mediates Df-elicited Th2 
pulmonary inflammation
As Dectin-2 can elicit generation of both cys-LTs and pro-
inflammatory cytokines, we next determined the contribution 
of these lipid mediators to Df-induced pulmonary inflamma-
tion in the adoptive transfer model. We generated BMCsGM-CSF 
BMCGM-CSF Dectin-2 mediates Df-elicited Th2  
pulmonary inflammation
We next assessed whether Dectin-2 influenced the ability of 
BMCsGM-CSF to initiate a Df-induced immune response in an 
adoptive transfer model. We stimulated day-7 kdBMCsGM-CSF 
and cBMCsGM-CSF with 100 µg/ml Df or saline for 24 h, 
adoptively transferred 104 cells into WT recipients by intranasal 
injection on day 8, challenged recipients with 2 µg Df intra-
nasally on day 22 and day 23, and euthanized the recipients   
for assay on day 25. Df-pulsed cBMCsGM-CSF were able to sensi-
tize recipients for Df challenge, inducing a robust inflammatory 
response with recruitment of mononuclear cells, neutrophils, 
and eosinophils in bronchoalveolar lavage (BAL) fluid. After 
Df challenge, recipients sensitized with kd-BMCsGM-CSF had 
significant reductions in total cell counts of 43.6%, in mono-
nuclear cells of 28.9%, in neutrophils of 65.9%, and in eosino-
phils of 70.3%, as compared with recipients of cBMCsGM-CSF 
(Fig. 2 A). To determine whether the reduction in BAL 
fluid inflammation was associated with a reduction in T cell 
cytokines, ELISA was performed on the BAL fluid superna-
tants for IL-13, IL-17A, and IFN- (Fig. 2 B). Recipients sensi-
tized with kdBMCsGM-CSF had a significant 59.7% reduction   
in BAL fluid IL-13, as compared with mice sensitized with 
cBMCsGM-CSF. The levels of IL-17A and IFN- were below 
the limits of detection.
Figure 3.  BMCGM-CSF Dectin-2 is required for lymph node Th2 cyto-
kine production elicited by Df. WT mice were sensitized with saline-
pulsed or Df-pulsed kdBMCsGM-CSF or cBMCsGM-CSF and challenged with Df as 
described in the Fig. 2 legend. Parabronchial lymph node cells were isolated, 
counted, and restimulated for 72 h with 0, 1, or 5 µg/ml Df, and cytokines in 
the supernatant were measured by ELISA. Total cytokine production per 
mouse is shown. Results are means ± SEM (n = 10–13 mice per group) from 
three independent experiments. Triangles under x axes indicate 0, 1, and 5 
µg/ml Df, from left to right. *, P = 0.04; **, P = 0.01; ***, P = 0.007; ‡, P = 
0.03. Significance was determined with an unpaired Student’s t test.
Figure 4.  BMCGM-CSF LTC4S is required for Df-elicited eosinophilic 
pulmonary inflammation. WT mice were sensitized by intranasal admin-
istration of 104 Df-pulsed WT or Ltc4s/ BMCsGM-CSF, challenged with  
2 µg Df on day 22 and day 23, and analyzed on day 25. Cells from the BAL 
fluid were counted, cytospin preparations were stained, and 400 cells/
slide were counted for specific cell types. Results are means ± SEM  
(n = 13–14 mice per group) from four independent experiments. ***, P = 
0.0001. Significance was determined with an unpaired Student’s t test.JEM VOL. 208, March 14, 2011 
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produced IL-4, IL-5, IL-17A, and IFN- (Fig. 5 B and   
Fig. S3). There was no significant induction of these cyto-
kines from CD8+ T cells. Recipients of Df-pulsed Ltc4s/ 
BMCsGM-CSF had a significant 68.6% reduction in the num-
ber of IL-4+ CD4+ T cells and a significant 73.0% reduction 
in the number of IL-5+CD4+ T cells, as compared with mice 
sensitized  with  Df-pulsed WT  BMCsGM-CSF,  whereas  the 
numbers of IL-17A+ and IFN-+CD4+ T cells were un-
changed. Thus, the selective decline in BAL fluid eosinophils   
was paralleled by a selective reduction in Th2 cells recruited 
to lung.
We next assessed the lung-draining lymph nodes to deter-
mine whether the profile of cytokine production was simi-
larly impaired. Cells from the lung-draining lymph nodes of 
sensitized and challenged recipients were restimulated ex vivo 
with Df at 0, 1, or 5 µg/ml, and cytokines in the superna-
tant were measured at 72 h. Recipients sensitized with Df-
pulsed WT BMCsGM-CSF generated robust production of T 
cell cytokines, as compared with recipients of saline-pulsed 
WT BMCsGM-CSF. Mice sensitized with Df-pulsed Ltc4s/ 
BMCsGM-CSF had significant reductions in the total genera-
tion of IL-4, IL-5, and IL-13 per mouse of 61.5, 76.4, and 
78.2%, respectively, as compared with mice sensitized with 
from  BALB/c WT  and  LTC4S-deficient  (Ltc4s/)  mice, 
pulsed them with Df, sensitized WT recipients via intranasal 
transfer of Df-pulsed BMCsGM-CSF, and challenged recipients 
intranasally with Df to elicit memory responses. Whereas WT 
BMCsGM-CSF sensitized recipients for robust pulmonary in-
flammation with recruitment of mononuclear cells, neutro-
phils,  and  eosinophils  to  the  airway,  mice  sensitized  with 
Df-pulsed Ltc4s/ BMCsGM-CSF had a selective 78.4% reduc-
tion in the recruitment of eosinophils to the BAL fluid with 
Df challenge (Fig. 4).
To determine whether the attenuation of eosinophil re-
cruitment in mice sensitized with Ltc4s/ BMCsGM-CSF re-
flected a decrement in Th2 cells in the lung, we characterized 
the CD4+ and CD8+ T cell populations recruited to the lung 
in another cohort sensitized and challenged in the same man-
ner. Pulmonary mononuclear cells were isolated, stimulated 
with PMA and ionomycin in the presence of monensin, per-
meabilized, and stained for CD4, CD8, IL-4, IL-5, IL-17A, 
and IFN-. Fig. 5 A shows that mice sensitized with Df-pulsed 
WT BMCsGM-CSF and challenged with Df had recruitment of 
both CD4+ and CD8+ T cells to the lung, as compared with 
mice  sensitized  with  saline-pulsed WT  BMCsGM-CSF.  Re-
cruitment of CD4+ and CD8+ T cells was significantly re-
duced by 44.4 and 41.9%, respectively, in mice sensitized with 
Df-pulsed  Ltc4s/  BMCsGM-CSF.  Recruited  CD4+ T  cells 
Figure 5.  BMCGM-CSF LTC4S is required for Df-elicited CD4+ Th2 
cell recruitment to the lung. WT mice were sensitized with saline-
pulsed or Df-pulsed WT or Ltc4s/ BMCsGM-CSF and challenged with Df as 
described in the legend to Fig. 4. Pulmonary mononuclear cells were iso-
lated, stimulated with 50 ng/ml PMA and 1 µM ionomycin for 10 h in the 
presence of 2.5 µM monensin, stained for cell surface expression of CD4 
and CD8 (A) and for intracellular expression of IL-4, IL-5, IL-17A, and  
IFN- (B), and analyzed by flow cytometry. Gating on cell size, on CD4 and 
CD8 expression, the total number of cells recruited to the lung is shown. 
Results are means ± SEM (n = 11 mice per group) from two experiments. 
*, P = 0.02; **, P = 0.005; ***, P = 0.002; ****, P = 0.0008. Significance was 
determined with an unpaired Student’s t test.
Figure 6.  BMCGM-CSF LTC4S is required for lymph node Th2 cyto-
kine production elicited by Df. WT mice were sensitized with saline-
pulsed or Df-pulsed WT or Ltc4s/ BMCsGM-CSF and challenged with Df as 
described in the legend to Fig. 4. Parabronchial lymph node cells were 
isolated, counted, and restimulated for 72 h with 0, 1, or 5 µg/ml Df, and 
cytokines in the supernatant were measured by ELISA. Total cytokine pro-
duction per mouse is shown. Results are means ± SEM (n = 12–15 mice 
per group) from three experiments. Triangles under x axes indicate 0, 1, 
and 5 µg/ml Df, from left to right. *, P = 0.04; **, P = 0.001; ***, P = 0.0001. 
Significance was determined with an unpaired Student’s t test.598 Dectin-2 drives Th2 responses in vivo | Barrett et al.
CysLT1R function conditions BMCsGM-CSF for Th2  
immune responses
We next sought to determine whether the Th2 priming func-
tion of cys-LTs was mediated through CysLT1R. WT recipi-
ents were sensitized by intranasal transfer of Df-pulsed WT or 
CysLT1R-deficient  (Cysltr1/)  BMCsGM-CSF  and  directly 
challenged with Df. Although Df-pulsed WT BMCsGM-CSF 
initiated a characteristic robust pulmonary inflammation with 
the recruitment of mononuclear cells, neutrophils, and eosin-
ophils to the airway, mice sensitized with Df-pulsed Cysltr1/ 
BMCsGM-CSF had a selective 45.1% reduction in eosinophil 
recruitment to the BAL fluid (Fig. 7). Restimulation of lung-
draining lymph node cells demonstrated that recipients sensi-
tized  with  Df-pulsed WT  BMCsGM-CSF  generated  robust 
production of T cell cytokines, as compared with recipients of 
saline-pulsed WT BMCsGM-CSF. At 5 µg/ml Df, mice sensi-
tized with Df-pulsed Cysltr1/ BMCsGM-CSF had significant 
reductions in the total generation of IL-5 and IL-13 per mouse 
of 53.7 and 47.4%, respectively, as compared with recipients 
of Df-pulsed WT BMCsGM-CSF, and a 69.3% fall in IL-4 that 
did not reach statistical significance (Fig. 8). The reductions in 
IL-5 and IL-13 were the result of a significant 36.7% reduc-
tion in the total lymph node cell count (Fig. 8). There was no 
significant difference in the generation of IL-17A or IFN- 
between mice sensitized with WT BMCsGM-CSF or Cysltr1/ 
BMCsGM-CSF. Thus, Cysltr1/ BMCsGM-CSF had a selective 
impairment in the generation of Th2 immunity that was 
similar to the findings with Ltc4s/ BMCsGM-CSF.
Cys-LTs mediate Df-elicited active sensitization and Th2 
pulmonary inflammation
To demonstrate that cys-LT generation and CysLT1R func-
tion are each required for Th2 pulmonary inflammation to Df 
in a direct immunization model, we sensitized and challenged 
Df-pulsed WT BMCsGM-CSF (Fig. 6). The reduction in IL-4, 
IL-5, and IL-13 generation by recipients of Df-pulsed Ltc4s/ 
BMCsGM-CSF was the result of both a reduction in concentra-
tion of each cytokine per million cells plated and a 20.5% re-
duction  in  the  total  lymph  node  cell  count  (Fig.  6). The 
reductions in concentration were significant for IL-5 and 
IL-13, whereas the trend for IL-4 did not reach significance. 
There was no difference in the total generation of IL-17A or 
IFN- per mouse. Thus, the attenuation in pulmonary eosin-
ophil and Th2 cell recruitment to the lung in mice sensitized 
with Df-pulsed Ltc4s/ BMCsGM-CSF appeared to reflect a 
selective defect in Th2 immunity to Df.
To confirm that MHCII-dependent antigen presentation 
by BMCsGM-CSF was required to sensitize recipient mice for 
the generation of eosinophilic pulmonary inflammation and 
Th2 cytokine induction after Df challenge, we sensitized WT 
C57BL/6  mice  with  Df-pulsed WT  or  MHCII-deficient 
(MHCII/) BMCsGM-CSF. After Df challenge, recipients of 
Df-pulsed MHCII/ BMCsGM-CSF had significant reductions 
in BAL fluid total cells of 88.3%, in monocytes of 66.9%, in 
neutrophils of 97%, and in eosinophils of 99%, as compared 
with recipients of Df-pulsed WT BMCsGM-CSF (Fig. S4 A). 
Lymph node cells were isolated, stimulated with PMA and 
ionomycin in the presence of monensin, permeabilized, and 
stained for CD4, CD8, IL-4, IL-5, IL-17A, and IFN-. As 
shown for a representative plot (Fig. S4 B), IL-4, IL-5, and IL-
17A were induced in CD4+ lymphocytes from recipients of 
WT, but not MHCII/, BMCsGM-CSF. We did not detect IL-4, 
IL-5, or IL-17A in any other cell population. Thus, MHCII-
mediated antigen presentation from transferred BMCsGM-CSF 
was necessary to sensitize WT recipients for the appearance of 
a cellular infiltrate in the BAL fluid and CD4+ Th2 cells in the 
draining lymph nodes.
Th2 differentiation may be altered by the maturation of 
DCs,  their  expression  of  costimulatory  molecules,  their 
production of proinflammatory cytokines, or their ability to 
migrate to the lung-draining lymph nodes. Flow cytometry 
revealed  comparable  cell  surface  expression  of  CD80, 
CD86,  CD40,  OX40L,  CCR7,  PD-L1,  and  ICOSL  on 
CD11c+MHCII+ WT  and  Ltc4s/  BMCsGM-CSF  after  Df 
loading (Fig. S5). We assessed cytokine production by WT and 
Ltc4s/ BMCsGM-CSF stimulated with Df and found no 
significant difference in the ability to generate TNF, IL-10, 
IL-6, IL-2, or IL-23 (Fig. S6). IL-12p70 was not detected 
from WT or Ltc4s/ BMCsGM-CSF (unpublished data). BMC-
sGM-CSF  can  chemotax  to  LTD4  in  a  CysLT1R-dependent 
fashion, and cys-LTs have been reported to enhance DC mi-
gration to the DC chemotactic ligand for CCR7, CCL19 
(Robbiani et al., 2000). We conjugated Df to Alexa Fluor 647 
and assessed the migration of intranasally transferred Alexa 
Fluor  647–Df-pulsed  BMCsGM-CSF  to  the  regional  lymph 
nodes 24 h later. We found that Alexa Fluor 647–Df-pulsed 
WT  and  Ltc4s/  BMCsGM-CSF  trafficked  to  the  regional 
lymph nodes to a similar extent and comprised 7.9 ± 0.75 
and 13.5 ± 4.7% of CD11chiMHCIIhi cells, respectively, at   
24 h over two experiments (Fig. S7).
Figure 7.  Df-elicited eosinophilic pulmonary inflammation is  
dependent on BMCGM-CSF CysLT1R. WT mice were sensitized with intrana-
sal administration of 104 Df-pulsed WT or Cysltr1/ BMCsGM-CSF, chal-
lenged with 2 µg Df on day 22 and day 23, and analyzed on day 25. Cells 
from the BAL fluid were counted, cytospin preparations were stained, and 
400 cells/slide were counted for specific cell types. Results are means ± 
SEM (n = 6–7 mice per group) from two experiments. **, P = 0.02. Signifi-
cance was determined with an unpaired Student’s t test.JEM VOL. 208, March 14, 2011 
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sensitized and challenged BALB/c mice with intranasal Df 
and treated them with a monoclonal antibody to Dectin-2 or 
the rat IgG2a isotype control on days 0, 2, 15, and 17. Mice 
treated with the Dectin-2 antibody had significant reductions 
in BAL fluid total cells (64%), mononuclear cells (61%), neu-
trophils (78%), and eosinophils (80%), as compared with mice 
treated with the isotype control (Fig. 10 A). Cytokines from 
restimulated lung-draining lymph node cells demonstrated 
that mice treated with the Dectin-2 antibody had significant 
reductions in the total generation of IL-4, IL-5, IL-13, and 
IL-17A per mouse of 47, 55, 44, and 90%, respectively, as 
WT, Ltc4s/, and Cysltr1/ mice on a BALB/c background 
with intranasal Df on days 0, 1, 15, and 16 and assessed pul-
monary inflammation in the BAL fluid and Th2 cytokine pro-
duction from restimulated lung-draining lymph node cells. 
Although WT mice developed a neutrophilic and eosinophilic 
inflammatory response in the BAL fluid (Fig. 9 A), Ltc4s/ 
and Cysltr1/ mice had significant reductions in eosinophil 
recruitment by 48 and 76%, respectively. Cysltr1/ mice had 
an additional reduction in neutrophil recruitment to the BAL 
fluid that did not reach statistical significance. Cytokines from 
restimulated lung-draining lymph node cells showed signifi-
cant 53 and 57% reductions in IL-4 and significant 54 and 
50% reductions in IL-5 in Ltc4s/ and Cysltr1/ mice, re-
spectively, as compared with WT (Fig. 9 B). Cysltr1/ mice 
had a significant 63% reduction in IL-13, whereas in Ltc4s/ 
mice the reduction did not reach statistical significance. There 
were additional reductions in IL-17A and in IFN- from 
Cysltr1/ mice that did not reach statistical significance.
Dectin-2 mediates Df-elicited active sensitization and Th2 
pulmonary inflammation
Finally, to assess the role of Dectin-2 in Df-elicited Th2 pul-
monary inflammation in the direct immunization model, we 
Figure 8.  Df-elicited Th2 cytokine generation is dependent on 
BMCGM-CSF CysLT1R. WT mice were sensitized with saline-pulsed or Df-
pulsed WT or Cysltr1/ BMCsGM-CSF and challenged with Df as described 
in the legend to Fig. 7. Parabronchial lymph node cells were isolated, 
counted, and restimulated for 72 h with 0, 1, or 5 µg/ml Df, and cytokines 
in the supernatant were measured by ELISA. Total cytokine production per 
mouse is shown. Results are means ± SEM (n = 7 mice per group) from 
two experiments. Triangles under x axes indicate 0, 1, and 5 µg/ml Df, 
from left to right. *, P = 0.03; **, P = 0.02. Significance was determined 
with an unpaired Student’s t test.
Figure 9.  Df-elicited eosinophilic pulmonary inflammation and 
Th2 cytokine generation is dependent on LTC4S and CysLT1R. WT 
(black), Ltc4s/ (white), or Cysltr1/ (gray) mice were sensitized with  
10 µg Df or saline on days 0 and 1, challenged with 10 µg Df on days 15 and 
16, and analyzed on day 18. (A) Cells from the BAL fluid were counted, 
cytospin preparations were stained, and 400 cells/slide were counted for 
specific cell types. Results are means ± SEM (n = 7–12 mice per group) 
from three experiments. *, P = 0.05; **, P = 0.01. (B) Parabronchial lymph 
node cells were isolated, counted, and restimulated for 72 h with 0 or  
5 µg/ml Df, and cytokines in the supernatant were measured by ELISA. 
Total cytokine production per mouse is shown. Results are means ± SEM 
(n = 7–12 mice per group) from three experiments. *, P = 0.05; **, P = 0.01;  
***, P = 0.001. Significance was determined with a one-way ANOVA.600 Dectin-2 drives Th2 responses in vivo | Barrett et al.
DISCUSSION
PRR signaling is central to the initiation of Th1 and Th17 
adaptive  immune  responses. We  have  previously  identified 
Dectin-2 on pulmonary CD11c+ cells and on BMCsGM-CSF as 
a PRR for clinically relevant allergens including Df, Dp, and 
Aspergillus fumigatus extract (Barrett et al., 2009). In this study, 
we demonstrate that Dectin-2 activation elicited by Df in 
both adoptive transfer and direct sensitization and challenge 
models triggers Th2 pulmonary inflammation and that this 
coupling is mediated through the specific actions of cys-LTs. 
Notably, TLR4 on lung stromal cells is the only PRR previ-
ously identified that links HDM recognition to Th2 pulmo-
nary inflammation (Hammad et al., 2009). Arachidonic acid 
release and cys-LT generation can be elicited by signaling 
from other myeloid CLRs, such as Dectin-1 and DC-SIGN 
(Olynych et al., 2006; Suram et al., 2006; Valera et al., 2007), 
and although these receptors recognize glycans that can serve 
as adjuvants for a Th2 response (Shreffler et al., 2006; Inoue   
et al., 2009), no mechanism for this linkage has been suggested. 
Herein, we observe a link to Th2 immunity not only via 
Dectin-2–mediated generation of cys-LTs from BMCsGM-CSF 
but also via CysLT1R function on these cells.
Both human DCs and mouse BMCsGM-CSF express the 
CysLT1R, and two prior pharmacologic studies with CysLT1R 
antagonists show that cys-LTs can augment Th2 sensitization 
in BALB/c mice (Machida et al., 2004; Okunishi et al., 2004). 
In WT mice sensitized by the adoptive transfer of Df-pulsed 
BMCsGM-CSF and challenged with Df, the recruitment of 
eosinophils to lung and the levels of IL-5 in BAL fluid were 
increased by costimulation with LTD4 and suppressed by the 
presence of a CysLT1R antagonist during the in vitro Df puls-
ing  (Machida  et  al.,  2004).  Systemic  administration  of  a 
CysLT1R antagonist during OVA sensitization reduced the 
levels of BAL fluid IL-4, IL-5, and IFN- elicited by OVA 
challenge (Okunishi et al., 2004). However, in the current 
study, the reductions in Th2 cytokines in restimulated lymph 
node cells were not accompanied by a reduction in IFN- 
production  in WT  recipients  sensitized  with  BMCsGM-CSF 
lacking LTC4S or CysLT1R.
Our findings for a CysLT1R function on BMCsGM-CSF in 
Th2 sensitization prompt a consideration of possible path-
ways. We did not find evidence for impaired generation of 
cytokines such as TNF from Ltc4s/ BMCsGM-CSF in re-
sponse to Df (Fig. S6). Nor did we detect any difference in 
maturation or expression of costimulatory markers between 
Df-pulsed WT and Ltc4s/ BMCsGM-CSF (Fig. S5). Cys-LTs 
can specifically modulate human and mouse DC migration 
(Robbiani et al., 2000; Thivierge et al., 2006), but we did not 
see any impairment in the migration of Alexa Fluor 647–
Df-pulsed Ltc4s/ BMCsGM-CSF to the lung-draining lymph 
nodes, as compared with WT controls (Fig. S7). The CysLT1R 
ligand, LTD4, can stimulate human neutrophil adhesion to in-
tercellular adhesion molecule 1 in a manner that is dependent on 
the 2 integrin CD18 and is blocked by the selective CysLT1R 
antagonist montelukast (Meliton et al., 2010). Moreover, LTD4 
can promote 41 and 51 integrin–dependent adhesion of 
compared with mice treated with the isotype control (Fig. 10 B). 
The reduction in IL-4, IL-5, and IL-13 generation by mice 
treated with the Dectin-2 antibody was the result of a 72% 
reduction in the total lymph node cell count, whereas the re-
duction in IL-17A was the result of both a reduction in the 
concentration of each cytokine per million cells plated and 
the reduction in the total lymph node cell count (Fig. 10 B).
Figure 10.  Df-elicited pulmonary inflammation and Th2 cytokine 
generation is dependent on Dectin-2. WT mice were sensitized and 
challenged as described in the Fig. 9 legend. Mice were injected intraperi-
toneally with 200 µg Dectin-2 antibody or a rat IgG2a isotype control on 
days 0, 2, 15, and 17, and analyzed on day 18. (A) Cells from the BAL fluid 
were counted, cytospin preparations were stained, and 400 cells/slide were 
counted for specific cell types. (B) Parabronchial lymph node cell counts. 
Results are means ± SEM (n = 4 mice per group) and are representative of 
two independent experiments. *, P = 0.04; **, P = 0.02; ***, P = 0.01.  
(B) Parabronchial lymph node cells were isolated, counted, and restimu-
lated for 72 h with 0 or 5 µg/ml Df, and cytokines in the supernatant were 
measured by ELISA. Total cytokine production per mouse is shown. Results 
are means ± SEM (n = 4 mice per group) and are representative of two 
independent experiments. *, P = 0.04; **, P = 0.03; ***, P = 0.01; ‡, P = 
0.0001. Significance was determined with an unpaired Student’s t test.JEM VOL. 208, March 14, 2011 
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with Df-pulsed Ltc4s/ BMCsGM-CSF was also comparable 
to that in mice sensitized with Df-pulsed WT BMCsGM-CSF. 
Th17 immunity to dust mite may be generated by signal-
ing from other PRRs during sensitization. After intranasal 
sensitization and challenge with Dp, airway neutrophilia and 
Dp-specific IL-17A production by restimulated lymph node 
cells was attenuated in BALB/c mice lacking MyD88 (Phipps   
et al., 2009). Thus, signaling from another TLR or an IL-1 
family member may contribute to the Df-elicited Th17 prim-
ing in our adoptive transfer model. In addition, HDM extracts 
may activate other Syk/CARD9-dependent CLRs to elicit a 
Th17 response, as the addition of the Dectin-1 agonist curd-
lan to OVA immunization augments IL-17 production from   
restimulated lymphocytes in WT but not Dectin-1–null mice 
(LeibundGut-Landmann et al., 2007). Interestingly, Dectin-2 
may have a more significant role in Df-elicited Th17 im-
munity at the challenge phase, as we did find a reduction in 
IL-17A production in restimulated lymphocytes from mice 
treated with the Dectin-2 antibody during both the sensitiza-
tion and challenge.
In the adoptive transfer model, although the reduction in 
eosinophil recruitment to the BAL fluid in mice sensitized with 
Df-pulsed kdBMCsGM-CSF paralleled the reduction in lung and 
lymph node Th2 responses and was dependent on BMCsGM-CSF 
cys-LT production and CysLT1R-mediated function, the sig-
nificant fall in Dectin-2–dependent neutrophil recruitment to 
the BAL fluid was not accompanied by a reduction in IL-17A 
and  was  not  dependent  on  cys-LTs.  Dectin-2  activates  the 
FcR chain–, Syk-, and CARD9-dependent signaling pathway 
in DCs. This pathway is shared with macrophage-inducible   
C-type lectin for the production of neutrophil chemoattrac-
tants, such as CXCL2, in mouse macrophages (Yamasaki et al., 
2008), suggesting a mechanism by which Dectin-2 signaling 
may recruit neutrophils independently of IL-17A.
Earlier in vivo studies identified a role for Dectin-2 sig-
naling in the generation of Th17 immunity to C. albicans 
(Robinson et al., 2009; Saijo et al., 2010) and in regulatory   
T cell function in a model of UV radiation–induced toler-
ance (Aragane et al., 2003). Our study not only extends the 
biology of Dectin-2 to Th2 cells but also provides a link via 
the cys-LT pathway to pathological Th2 inflammation elic-
ited by HDM, the most common aeroallergen worldwide.
MATERIALS AND METHODS
Reagents and mice. Lyophilized extracts of Df (Greer Laboratories) were 
reconstituted  in  endotoxin-free  PBS  (Sigma-Aldrich).  DNase-1  (Roche), 
ionomycin (Calbiochem), and collagenase IV (Worthington Biochemical) 
were obtained as noted. LPS from E. coli O55:B5, curdlan, PMA, monensin, 
and puromycin were obtained from Sigma-Aldrich. Ltc4s/ mice on a 
BALB/c background (N10 and N11), Cysltr1/ mice on a BALB/c back-
ground (N10), and WT littermate controls were generated and maintained in 
our laboratory (Kanaoka et al., 2001; Maekawa et al., 2002). MHCII/ mice 
and  the  C57BL/6  controls  were  obtained  from The  Jackson  Laboratory 
(Madsen et al., 1999). All studies were approved by the Institutional Animal 
Care and Use Committee of the Dana-Farber Cancer Institute.
BMCsGM-CSF generation and Df stimulation. BMCsGM-CSF were gener-
ated with GM-CSF, as previously described (Barrett et al., 2009), according 
human CD34+ hematopoietic progenitor cells to endothelial 
cells, vascular cell adhesion molecule 1, and fibronectin, and such 
adhesion is blocked by CysLT1R antagonism (Boehmler et al., 
2009). As CD18/CD11a and the 41 integrin are critical 
membrane proteins recruited to the DC–T cell immune synapse, 
CysLT1R facilitation of cell–cell adhesion and the organization 
of the immune synapse may be a mechanism by which 
CysLT1R can promote nascent Th2 immune responses.
GM-CSF–expanded  BM  cultures  at  day  7  provide  a 
mixed population of cells, including Dectin-2 granulocytes 
(12.4 ± 0.5%; Fig. S1 C) and Dectin-2+CD11c cells (7.0 ± 
0.5%) that express CD11b and Ly6C, presumably identifying 
Dectin-2+ monocytes in this culture. The dominant CD11c+ 
cell population in these cultures expresses CD11b (97.7 ± 
0.4%) and MHCII (88.5 ± 2%). Such cells, termed inflamma-
tory DCs, were recently identified as the critical antigen- 
presenting cells to drive Th2 responses to HDM (Hammad   
et al., 2010), and our findings suggest that Dectin-2 expression 
on these cells may be central to this function. As Dectin-2 is 
highly expressed on immature CD11chiMHCIIlow cells (Fig. 1 A 
and  Fig.  S1 A),  further  studies  are  needed  to  determine 
whether Dectin-2 expression identifies a particular subset of 
inflammatory DCs in vivo that prime for Th2 immunity.
We found a significant role for Dectin-2–mediated cys-
LT production and CysLT1R function in the generation of 
Th2 immunity to Df in both the adoptive transfer studies 
with Df-pulsed BMCsGM-CSF and the direct sensitization and 
challenge of LTC4S- and CysLT1R-deficient strains. How-
ever, our studies do not exclude a contribution from the   
Df-elicited Dectin-2–dependent cytokines. The pharmacologic 
addition of TNF to OVA/LPS sensitization can restore pul-
monary DC activation and migration and the induction of 
eosinophilic  pulmonary  inflammation  that  is  impaired  in 
BALB/c mice with defective TLR4 signaling (Eisenbarth et al., 
2002). Mice with a targeted deletion of the IL-23 subunit 
p19 have attenuated Th2 pulmonary inflammation and spe-
cific IgE levels after i.p. sensitization with OVA/alum and 
intranasal challenge with OVA, which are associated with an 
impairment in T cell GATA-3 induction (Peng et al., 2010). 
Antigen-presenting cell–derived IL-6 can drive IL-4 produc-
tion from naive murine CD4+ T cells (Rincón et al., 1997), 
and neutralization of IL-6 in ex vivo lymph node cell cultures 
from mice sensitized with HDM-pulsed BMCsGM-CSF dimin-
ished the production of IL-13 (Krishnamoorthy et al., 2008). 
As the generation of TNF, IL-23, and IL-6 was blunted in   
kdBMCsGM-CSF,  these  mediators  may  also  contribute  to   
Df-induced Dectin-2–dependent Th2 immunopathology.
We found a robust Th17 immune response in mice re-
ceiving Df-pulsed WT BMCsGM-CSF and challenged with Df, 
as has been noted by others in protocols of intranasal sensi-
tization and challenge with HDM (Krishnamoorthy et al., 
2008; Phipps et al., 2009), but we did not find a significant 
attenuation in lymph node cell production of IL-17A in mice 
sensitized with Df-pulsed Ltc4s/ BMCsGM-CSF, Df-pulsed 
Cysltr1/  BMCsGM-CSF,  or  Df-pulsed  kdBMCsGM-CSF. The 
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lymph node restimulation. After adoptive transfer of BMCsGM-CSF from 
MHCII/ mice or C57BL/6 WT mice, recipient C57BL/6 mice were chal-
lenged with 10 µg Df intranasally on days 20, 22, and 24 and euthanized on 
day  25.  For  the  active  sensitization  and  challenge  protocol,  Ltc4s/, 
Cysltr1/, or BALB/c WT mice were sensitized (days 0 and 1) and chal-
lenged (days 15 and 16) with 10 µg Df intranasally and euthanized on day 18. 
For antibody blocking, 200 µg Dectin-2 antibody (clone D2.11E4; Thermo 
Fisher Scientific) or a rat IgG2a control (BioLegend) was injected intraperi-
toneally into BALB/c WT mice on days 0, 2, 15, and 17. On days 0 and 15 
the antibody was injected 6 h before Df.
BAL. Mice were killed, the trachea was exposed and cannulated with a 
22-gauge angiocatheter, and the bronchoalveolar space was lavaged three 
times with 0.75 ml PBS with 1 mM EDTA. The BAL fluid was centrifuged, 
and the pelleted cells were resuspended in PBS with 1% FCS and counted. 
Then, 1.5 × 105 cells in 200 µl were cytospun, fixed, and stained with Hema 
3 Stain Set (Thermo Fisher Scientific). Cells were identified by morphologi-
cal criteria. 400 cells per slide were counted. IL-13, IL-17A, and IFN- levels 
in the BAL fluid supernatants were measured by ELISA (eBioscience) with 
lower limits of detection at 7.8, 7.8, and 31.2 pg/ml, respectively.
Intracellular cytokine staining of pulmonary mononuclear cells and 
lymph node cells. For pulmonary mononuclear cell assessment, mice were 
killed, and the lungs were perfused with 10 ml of sterile PBS, homogenized 
with sterile scalpels, and digested in a shaker for 30 min with 500 U/ml of 
type IV collagenase and 0.02 mg/ml DNase I at 37°C. The cells were washed, 
filtered through a 70-µm cell strainer, and separated on a NycoPrep gradient 
(Axis-Shield) at 600 g for 20 min at 4°C. Harvested mononuclear cells were 
washed; resuspended in RPMI 1640 medium supplemented with 10% heat-
inactivated FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 0.1 mM non-
essential amino acids, 0.043 mM 2-ME, 2 mM l-glutamine, 0.025 M Hepes 
buffer, and 1 mM sodium pyruvate; plated at 2 × 106 cells/ml in 24-well 
plate; and stimulated with 50 ng/ml PMA and 1 µM ionomycin for 2 h at 
37°C. 2.5 µM monensin was added and the cells were incubated for an addi-
tional 8 h. Cells were harvested, treated with DNase I at a concentration of 
60 µg/ml for 15 min at 37°C, washed, fixed with fixation buffer (eBiosci-
ence) for 15 min, washed again, and blocked in 300 µl permeabilization buf-
fer (eBioscience) with 1% mouse IgG (Sigma-Aldrich) and 1% anti–mouse 
CD16/CD32 (BD) for 20 min. Cells were then stained with anti–mouse 
CD4-PE-Cy7  (clone  RM4-5;  BD),  anti–mouse  CD8-allophycocyanin 
(clone 53–6.7; BD), anti–mouse IL-4–PE (clone 11B11; BD), anti–mouse 
IL-5-PE (clone TRFK5; BD), anti–mouse IL-17A–PE (clone TC11-18H10; 
BD), anti–mouse IFN-–PE (clone XMG1.2; eBioscience), or rat IgG1-PE 
isotype control Ab (BD) at a concentration of 0.2 µg/0.1 ml/2 × 106 cells. 
Analyses were performed on a FACSCanto flow cytometer, and data were ana-
lyzed with FlowJo. For lymph node cell assessment, the parabronchial lymph 
nodes were excised from each mouse. Single cell suspensions were generated, 
filtered through a 70-µm cell strainer, washed, resuspended in the RPMI me-
dium described in this section, and counted. Cell stimulation, washing, fixa-
tion, permeabilization, and staining were as in this section with the exception 
that PMA, ionomycin, and then monensin treatment was done for a total of 
6 h, and cells were stained with anti–mouse CD4-allophycocyanin (clone 
RM4-5; BD) and anti–mouse CD8–PE-Cy7 (clone 53–6.7; BD).
Cytokine assays from lung-draining lymph nodes. Single cell suspen-
sions from the parabronchial lymph nodes were generated. Lymph node cells 
were cultured at 4 × 106 cells/ml with 0, 1, or 5 µg/ml Df for 72 h at 37°C 
in RPMI medium with 10% FCS. The concentrations of IL-4, IL-5, IL-13, 
IL-17A, and IFN- in the supernatants were measured with ELISA kits 
(eBioscience) with lower limits of detection at 39 pg/ml, 117 pg/ml, 390 
pg/ml, 39 pg/ml, and 156 pg/ml, respectively.  The total concentration of cyto-
kine generated per mouse is reported.
BMCGM-CSF migration. Df was conjugated to Alexa Fluor 647 with a Pro-
tein Labeling kit (Invitrogen) according to the manufacturer’s protocol and 
to the protocol for BM-derived DC generation by Lutz et al. (1999). In brief, 
BM cells were harvested and resuspended at 4 × 105 cells/ml in RPMI 1640 
medium supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, 
100 µg/ml streptomycin, 2 mM l-glutamine, 50 µM 2-mercaptoethanol, and 
40 ng/ml of recombinant mouse GM-CSF (Peprotech). 10 ml of this suspen-
sion was plated in each Petri dish and cultured at 37°C in a 5% CO2 incuba-
tor. On day 3 of culture, 10 ml of complete media with GM-CSF was added 
to each plate. On day 6 of culture, 10 ml of media with GM-CSF was ex-
changed from each plate. The floating cell population was harvested at day 7, 
washed, and counted. For cell stimulations, Df was used at the concentrations 
noted with a final cell concentration of 106 cells/ml.
Cytospin and immunocytochemistry. To assess the cell composition of 
day-7 cultures, 1.5 × 105 cells in 200 µl were cytospun, fixed, and stained 
with Hema 3 Stain Set (Thermo Fisher Scientific). Cells were identified by 
morphological criteria. 400 cells per slide were counted. To assess Dectin-2 
expression by immunocytochemistry, cells were fixed in 4% paraformalde-
hyde, washed, cytospun, and stained using the rat ABC staining system (Santa 
Cruz Biotechnology, Inc.), according to the manufacturer’s instructions. In 
brief, the slides were blocked with 1.5% goat serum, incubated with rat anti–
Dectin-2 (AbD Serotec) or a rat IgG2a isotype control Ab (BD) at 1:20 at 
25°C for 1 h, washed, and incubated with biotin-conjugated goat anti–rat 
antibody for 30 min. Detection was accomplished using avidin-biotinylated 
horseradish peroxidase and diaminobenzidine substrate. Hematoxylin was 
used for counterstaining. The pictures were taken by a digital camera (DXM 
1200; Nikon) with ACT-1 (version 2.70; Nikon) image acquisition software. 
500 cells per sample were assessed.
Flow cytometry. To assess Dectin-2 expression on day 7, BMCsGM-CSF were 
harvested, washed, blocked in PBS containing 1 mM EDTA and 10% donkey 
serum  (Jackson  ImmunoResearch  Laboratories,  Inc.),  and  serially  stained 
with rat anti–Dectin-2 (Abcam) or rat IgG2a isotype control Ab (BD) at   
1 µg/0.2 ml/106 cells, donkey anti–rat Ig-allophycocyanin (Jackson Immuno-
Research Laboratories, Inc.) at 1:100 dilution, and either rat anti–mouse 
CD11c-PECy7, MHCII-PE, CD80-PE, CD86-PE, CD40-PE, OX40L-PE, 
CCR7-PE, PD-L1-PE, and ICOSL-PE (BD) or rat anti–mouse CD11c- 
Pacific Blue, MHCII-FITC, CD11b-PECy7, and Ly6c-APCCy7 (eBiosci-
ence).  MHCII-PE  staining  was  performed  at  nonsaturating  antibody 
concentrations. Analyses were performed on a FACSCanto II flow cytometer 
(BD), and data were analyzed with FlowJo (7.5; Tree Star, Inc.).
Lentiviral knockdown of Dectin-2 in BMCsGM-CSF. Infectious viral par-
ticles were prepared and titered as previously described (Barrett et al., 2009) 
using the shRNA construct TRCN0000066785 for mouse Dectin-2 in the 
pLKO1 lentiviral vector (Open Biosystems), an empty vector control (Open 
Biosystems), and a nontargeting sequence (Sigma-Aldrich). BMCGM-CSF cul-
tures were begun on day 0, infected on day 1 at a multiplicity of infection of 
10, and selected with 2 µg/ml puromycin from days 4–7. BMCGM-CSF cul-
tures infected with lentivirus contained a mean of 76.8 ± 5% CD11c+ cells 
at day 7, as detected by flow cytometry.
Cys-LT and cytokine measurement. Cys-LTs in the supernatants of stimu-
lated cells were measured by enzyme immunoassay according to the manufactur-
er’s protocol (Cayman Chemical). The lower limit of detection was 3.9 pg/ml. 
IL-2, IL-6, IL-10, IL-23, and TNF were measured by ELISA (eBioscience) 
with lower limits of detection at 8, 78, 7.8, 7.8, and 156 pg/ml, respectively.
Sensitization and challenge protocols. For adoptive transfer of Df-pulsed 
BMCsGM-CSF into WT recipients and subsequent Df challenge, BMCsGM-CSF 
were grown to day 7 and stimulated with saline or Df at 100 µg/ml for 24 h. 
On day 8, nonadherent cells were washed twice in PBS, counted, and resus-
pended in PBS. WT recipient mice were sensitized intranasally with 104 
cells/50 µl, challenged with 2 µg Df intranasally on day 22 and day 23, and 
euthanized 48 h after the last challenge with an overdose of pentobarbital for 
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